164 related articles for article (PubMed ID: 3277171)
21. Increased PTHRP production by a tyrosine kinase oncogene, Tpr-Met: role of the Ras signaling pathway.
Aklilu F; Park M; Goltzman D; Rabbani SA
Am J Physiol; 1996 Aug; 271(2 Pt 1):E277-83. PubMed ID: 8770021
[TBL] [Abstract][Full Text] [Related]
22. Identification of tyrosine 489 in the carboxy terminus of the Tpr-Met oncoprotein as a major site of autophosphorylation.
Kamikura DM; Naujokas MA; Park M
Biochemistry; 1996 Jan; 35(3):1010-7. PubMed ID: 8547236
[TBL] [Abstract][Full Text] [Related]
23. TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines.
Soman NR; Wogan GN; Rhim JS
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):738-42. PubMed ID: 2300559
[TBL] [Abstract][Full Text] [Related]
24. Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS.
Testa JR; Park M; Blair DG; Kalbakji A; Arden K; Vande Woude GF
Oncogene; 1990 Oct; 5(10):1565-71. PubMed ID: 2250912
[TBL] [Abstract][Full Text] [Related]
25. The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.
Connelly PA; Stern DF
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6054-7. PubMed ID: 1974718
[TBL] [Abstract][Full Text] [Related]
26. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
[TBL] [Abstract][Full Text] [Related]
27. The met oncogene: a new member of the tyrosine kinase family and a marker for cystic fibrosis.
Park M; Gonzatti-Haces M; Dean M; Blair DG; Testa JR; Bennett DD; Copeland T; Oroszlan S; Vande Woude G
Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():967-75. PubMed ID: 3472770
[No Abstract] [Full Text] [Related]
28. yes-related protooncogene, syn, belongs to the protein-tyrosine kinase family.
Semba K; Nishizawa M; Miyajima N; Yoshida MC; Sukegawa J; Yamanashi Y; Sasaki M; Yamamoto T; Toyoshima K
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5459-63. PubMed ID: 3526330
[TBL] [Abstract][Full Text] [Related]
29. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors.
Park M; Dean M; Kaul K; Braun MJ; Gonda MA; Vande Woude G
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6379-83. PubMed ID: 2819873
[TBL] [Abstract][Full Text] [Related]
30. Isoforms of the met receptor tyrosine kinase.
Rodrigues GA; Park M
EXS; 1993; 65():167-79. PubMed ID: 8380736
[TBL] [Abstract][Full Text] [Related]
31. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias.
Amson R; Sigaux F; Przedborski S; Flandrin G; Givol D; Telerman A
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8857-61. PubMed ID: 2682662
[TBL] [Abstract][Full Text] [Related]
32. PDGF-independent activation of PDGF-beta receptors in NIH-3T3 cells transformed by c-met protooncogene.
Kochhar KS; Linnekin D; Iyer AP
Exp Cell Res; 1994 Jun; 212(2):414-21. PubMed ID: 7514539
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 2 induces tyrosine phosphorylation and activation of p72-74 Raf-1 kinase in a T-cell line.
Turner B; Rapp U; App H; Greene M; Dobashi K; Reed J
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1227-31. PubMed ID: 1996324
[TBL] [Abstract][Full Text] [Related]
34. Protooncogene-encoded protein kinases in interleukin-2 signal transduction.
Reed JC; Torigoe T; Turner BC; Merida I; Gaulton G; Saragovi HU; Rapp UR; Taichman R
Semin Immunol; 1993 Oct; 5(5):327-36. PubMed ID: 8260649
[TBL] [Abstract][Full Text] [Related]
35. The hepatocyte growth factor and its receptor.
Galimi F; Brizzi MF; Comoglio PM
Stem Cells; 1993 Jul; 11 Suppl 2():22-30. PubMed ID: 8401259
[TBL] [Abstract][Full Text] [Related]
36. Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes.
Shibuya M; Matsushime H; Yamazaki H; Wang LH; Fukui Y; Ueyama Y; Tamaoki N
Princess Takamatsu Symp; 1986; 17():195-202. PubMed ID: 3455414
[TBL] [Abstract][Full Text] [Related]
37. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
Michelin S; Daya-Grosjean L; Sureau F; Saïd S; Sarasin A; Suárez HG
Oncogene; 1993 Jul; 8(7):1983-91. PubMed ID: 8510940
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the close relationship between human astrocytoma-specific antigens detected by murine monoclonal antibodies and c-kit proto-oncogene product.
Kondo S; Miyatake S; Matsumoto M; Nakatsu S; Iwasaki K; Oda Y; Kikuchi H; Namba Y
Biochem Biophys Res Commun; 1992 Jan; 182(2):474-80. PubMed ID: 1370880
[TBL] [Abstract][Full Text] [Related]
40. Structure of the met protein and variation of met protein kinase activity among human tumour cell lines.
Tempest PR; Stratton MR; Cooper CS
Br J Cancer; 1988 Jul; 58(1):3-7. PubMed ID: 3048352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
